Stock Evaluator: Cencora, Inc. (COR)

Cencora, Inc. COR

$311.34 -0.89 -0.29%
July 31, 2026 4:00:03 PM EST November 10, 2021 Volume: 1,047,979
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Commentary & Analysis


Financial Summary

Share Statistics COR Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $60,574.6 $1,742.7 94%
Shares Out (Mil) 195.4 76.7 76%
Institutional Ownership 99.6% 89.7% 91%
Float (Mil) 184.0 49.4 72%
Beta 0.64 0.82 37%
Avg Daily Volume (000s) 1,066 521 72%
Price Change
(52-week)
6.7% 78.7% 51%
Growth COR Industry
Median
Percentile
(All Stocks)
Sales (5yr) 11.1% 11.0% 62%
Net Income (5yr) 19.7% (0.7%) 72%
EPS (5yr) 19.9% 3.1% 68
Dividends (5yr) 5.8% 0.0% 92%
Cash Flow (5yr) (1.1%) (18.0%) 64%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 12 13 14
Current EPS $4.348 $17.784 $19.817
Month Ago EPS $4.349 $17.772 $19.793
# Rev Up 2 0 0
# Rev Down 0 1 1
Three Months Ago EPS $4.322 $17.609 $19.606
Year/Year Chg (48.2%) 123.4% 175.9%
Financials COR Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $328,680 $1,456 100%
Net Income (TTM) (Mil) $2,549 $12 94%
EPS (TTM) $13.129 $0.300 96%
Operating Cash Flow (TTM) (Mil) $2,276 $138 89%
Net Cash Flow (TTM) (Mil) $82 $8 75%
Long-Term Debt (Q1) (Mil) $14,469 $316 94%
Enterprise Value (Q1) (Mil) $63,905 $2,170 94%
Valuation COR Industry
Median
Percentile
(All Stocks)
P/B 17.83 2.85 95%
P/E 23.9 26.7 59%
Dividend Yield 0.8% 0.0% 65%
PEG (5yr hist) 1.2 1.1 51%
Ratios COR Industry
Median
Percentile
(All Stocks)
Gross Margin 3.8% 27.8% 6%
Net Margin 0.8% 1.1% 34%
ROA 3.3% 1.8% 63%
ROE 115.6% 7.1% 97%
Liabilities to Assets 95.6% 59.9% 92%
F-Score 5 5 51%

Cencora, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors